---
figid: PMC6023766__nihms965177f2
figtitle: Control of the PI3K and RAS signaling pathways by phosphatase signaling
organisms:
- Homo sapiens
pmcid: PMC6023766
filename: nihms965177f2.jpg
figlink: /pmc/articles/PMC6023766/figure/F2/
number: F2
caption: Control of the PI3K and RAS signaling pathways by phosphatase signaling.
  Phosphatases that target components of one or both pathways are shown in violet.
  Arrows denote activating whereas bar-headed lines denote inhibitory effects. For
  simplicity, the intervening steps between stimulation of the various receptor types
  and PI3K/RAS pathway activation are not depicted. See text for further details.
  GPCR, G protein-coupled receptor; RTK, receptor tyrosine kinase.
papertitle: THE IMPACT OF PHOSPHATASES ON PROLIFERATIVE AND SURVIVAL SIGNALING IN
  CANCER.
reftext: Goutham Narla, et al. Cell Mol Life Sci. 2018 Aug;75(15):2695-2718.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9694535
figid_alias: PMC6023766__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6023766__F2
ndex: 1e85cd97-deba-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6023766__nihms965177f2.html
  '@type': Dataset
  description: Control of the PI3K and RAS signaling pathways by phosphatase signaling.
    Phosphatases that target components of one or both pathways are shown in violet.
    Arrows denote activating whereas bar-headed lines denote inhibitory effects. For
    simplicity, the intervening steps between stimulation of the various receptor
    types and PI3K/RAS pathway activation are not depicted. See text for further details.
    GPCR, G protein-coupled receptor; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - PDK1
  - PDPK1
  - PDK2
  - PTEN
  - MAP3K1
  - MAP3K2
  - MAP3K3
  - MAP3K4
  - MAP3K5
  - MAP3K6
  - MAP3K7
  - MAP3K8
  - MAP3K9
  - MAP3K10
  - MAP3K11
  - MAP3K12
  - MAP3K13
  - MAP3K14
  - MAP3K15
  - MAP3K19
  - MAP3K20
  - MAP3K21
  - TAOK1
  - TAOK2
  - TAOK3
  - MAP2K4
  - MAPK9
  - MAPK8
  - PTPA
  - PHLPP1
  - AKT1
  - AKT2
  - AKT3
  - PPP2R2A
  - DUSP1
  - DUSP4
  - DUSP2
  - PSMG1
  - MAP2K3
  - MAP2K6
  - DUSP6
  - DUSP9
  - DUSP10
  - DUSP16
  - DUSP5
  - DUSP8
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MINK1
  - KCNA1
  - EPCAM
  - LAMTOR3
  - PITRM1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
